Asia Green Biotechnology Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ASIA.CN research report →
Companywww.asiagreenbiotechnology.com
Asia Green Biotechnology Corp. , an early stage international bio-technology company, focuses on the development, evaluation, testing, application, and supply of products derived from proprietary organic hybridization technology in Asia. The company focuses on planting, growing, and harvesting new and valuable strains of hemp and related crops.
- CEO
- David Edward-Thomas Pinkman BA, LLB
- IPO
- 2019
- HQ
- Calgary, AB, CA
Price Chart
Valuation
- Market Cap
- $543.71K
- P/E
- -2.46
- P/S
- 0.00
- P/B
- -1.18
- EV/EBITDA
- 33.67
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 62.89%
- ROIC
- 64.57%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-221,000 · -11.62%
- EPS
- $-0.01 · 39.00%
- Op Income
- $-145,000
- FCF YoY
- 71.21%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 1.40
- Avg Volume
- 0
Get TickerSpark's AI analysis on ASIA.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ASIA.CN Coverage
We haven't published any research on ASIA.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ASIA.CN Report →